FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma

ConclusionsThe max SUVmax by FDG PET/CT of patients with RCC evaluated after their first molecular targeted therapy predicts OS. FDG PET/CT is a useful “imaging biomarker” for patients with advanced RCC planning sequential molecular targeted therapies.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research